US10584108B2ActiveUtilityA1
Therapeutic compounds and methods of use thereof
Est. expiryMay 7, 2035(~8.8 yrs left)· nominal 20-yr term from priority
Inventors:Chengguo Xing
C07C 2601/16C07C 2601/14C07D 407/06C07C 49/683C07C 2602/08C07D 309/32A61P 35/00C07C 49/657C07C 49/753C07D 317/54C07D 405/06
74
PatentIndex Score
1
Cited by
105
References
8
Claims
Abstract
The invention provides compounds that are useful for treating or preventing cancer.
Claims
exact text as granted — not AI-modifiedThe invention claimed is:
1. A compound of formula (Ic):
wherein:
the 5-membered ring that comprises two O atoms is optionally substituted with 1 or 2 groups independently selected from halo, hydroxy, cyano, trifluoromethyl, trifluoromethoxy, (C 1 -C 3 )alkyl, and (C 1 -C 3 )alkoxy;
X is CH;
A is —CH 2 CH 2 —, —CR b ═CH—, or —CH═CH—CH═CH—;
R 3 is H, or (C 1 -C 6 )alkyl;
Y is CH 2 ;
R 4 is H, halo, (C 1 -C 6 )alkyl, or (C 1 -C 6 )alkoxy;
R 5 is (C 1 -C 6 )alkoxy that is optionally substituted with phenyl;
R 6 is H, halo, (C 1 -C 6 )alkyl, or (C 1 -C 6 )alkoxy;
and
R b is H or phenyl that is optionally substituted with 1, 2, or 3 groups independently selected from halo, hydroxy, cyano, trifluoromethyl, trifluoromethoxy, (C 1 -C 3 )alkyl, and (C 1 -C 3 )alkoxy;
or a salt thereof.
2. The compound of claim 1 wherein the 5-membered ring that comprises two O atoms is not substituted.
3. The compound of claim 1 wherein A is —CH 2 CH 2 —.
4. The compound of claim 1 wherein R 3 is H.
5. The compound of claim 1 wherein R 5 is methoxy, ethoxy, propoxy, benzyloxy, or butoxy.
6. A compound selected from:
or a salt thereof.
7. A pharmaceutical composition comprising a compound as described in claim 1 , or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.
8. The compound of claim 4 , wherein A is —CH 2 CH 2 —.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.